WEDNESDAY, May 10, 2023 (HealthDay News) — Researchers have isolated for the first time a free-floating form of amyloid beta that appears to be a key driver of Alzheimer’s disease. Further, they argue that a newly approved Alzheimer’s drug — lecanemab (Leqembi) — directly targets these small, complex chains ofContinue Reading

FRIDAY, May 5, 2023 (HealthDay News) — Getting good sleep is an important part of wellness for many reasons, but new research suggests deep sleep may even guard against memory loss linked to Alzheimer’s. While disrupted sleep has been linked with accumulating beta-amyloid plaques in the brain faster, scientists foundContinue Reading

WEDNESDAY, May 3, 2023 (HealthDay News) — Another experimental drug meant for Alzheimer’s disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June. Known as donanemab, the medication clears amyloid plaque from the brain. InContinue Reading

FRIDAY, April 21, 2023 (HealthDay News) – Taking a particular sleep medication may help stave off Alzheimer’s disease, but it’s too soon to say for sure after a preliminary study. Researchers at Washington University School of Medicine in St. Louis found that participants who took a sleeping pill called suvorexantContinue Reading

FRIDAY, April 14, 2023 (HealthDay News) — Cutting-edge AI technologies that can detect subtle changes in a person’s voice may help doctors diagnose Alzheimer’s disease and other cognitive impairments even before other symptoms begin. In a new study, researchers used advanced machine learning and natural language processing (NLP) tools toContinue Reading

WEDNESDAY, April 5, 2023 (HealthDay News) — A new national Alzheimer’s disease and dementia database could be a game changer for research on the memory-robbing condition that now affects more than 6 million Americans. Planning has begun at the National Institute on Aging (NIA) to fund the data platform. AContinue Reading